Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

SCOS Padilha, S Virtuoso, FS Tonin… - European child & …, 2018 - Springer
The aim of this study is to gather evidence of head-to-head double-blind randomized-
controlled trials on the efficacy and safety of available treatments for attention deficit …

[HTML][HTML] The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with …

F Catalá-López, B Hutton, A Núñez-Beltrán, MJ Page… - PloS one, 2017 - journals.plos.org
Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used …

[HTML][HTML] The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic …

F Catalá-López, B Hutton, A Núñez-Beltrán… - Systematic reviews, 2015 - Springer
Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders of children and adolescents, with a significant impact on …

An evaluation on the efficacy and safety of treatments for attention deficit hyperactivity disorder in children and adolescents: a comparison of multiple treatments

Y Li, J Gao, S He, Y Zhang, Q Wang - Molecular neurobiology, 2017 - Springer
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral
disorders. We carried out this comparison of multiple treatments based on sufficient data in …

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a …

S Cortese, N Adamo, C Mohr-Jensen, AJ Hayes… - BMJ open, 2017 - bmjopen.bmj.com
Introduction Attention-deficit/hyperactivity disorder (ADHD) is a major public health issue.
Pharmacological treatments play an important role in the multimodal treatment of ADHD …

[HTML][HTML] Efficacy and tolerability of different interventions in children and adolescents with attention deficit hyperactivity disorder

R Luan, Z Mu, F Yue, S He - Frontiers in psychiatry, 2017 - frontiersin.org
Background Our study is an analysis of multiple publications involving assessing the
comparable efficacy and tolerability of six interventions, which are lisdexamfetamine …

[HTML][HTML] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - thelancet.com
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies

A Klassen, A Miller, P Raina… - The Canadian Journal …, 1999 - journals.sagepub.com
Objective: To obtain estimates of the relative efficacy of 3 main treatment strategies for
attention-deficit hyperactivity disorder (ADHD) in children and youth (age< 18 years) …

Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review

E Chan, JM Fogler, PG Hammerness - Jama, 2016 - jamanetwork.com
Importance Although attention-deficit/hyperactivity disorder (ADHD) is highly prevalent in
adolescents and often persists into adulthood, most studies about treatment were performed …

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in …

M Stuhec, B Munda, V Svab, I Locatelli - Journal of affective disorders, 2015 - Elsevier
Objectives There is a lack of comparative effectiveness research among attention deficit
hyperactivity disorder (ADHD) drugs in terms of efficacy and acceptability, where bupropion …